HEADER SIGNALING PROTEIN 09-NOV-21 7Q7I TITLE JAK2 IN COMPLEX WITH 4-{8-METHOXY-2-[(1-METHYL-1H-PYRAZOL-4-YL) TITLE 2 AMINO]QUINAZOLIN-6-YL}PHENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS JAK2, JANUS KINASE 2, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.ROWLAND REVDAT 2 01-MAY-24 7Q7I 1 REMARK REVDAT 1 02-FEB-22 7Q7I 0 JRNL AUTH C.R.WELLAWAY,I.R.BALDWIN,P.BAMBOROUGH,D.BARKER, JRNL AUTH 2 M.A.BARTHOLOMEW,C.W.CHUNG,B.DUMPELFELD,J.P.EVANS, JRNL AUTH 3 N.J.FAZAKERLEY,P.HOMES,S.P.KEELING,X.Q.LEWELL,F.W.MCNAB, JRNL AUTH 4 J.MORLEY,D.NEEDHAM,M.NEU,A.J.M.VAN OOSTERHOUT,A.PAL, JRNL AUTH 5 F.B.M.REINHARD,F.RIANJONGDEE,C.M.ROBERTSON,P.ROWLAND, JRNL AUTH 6 R.R.SHAH,E.B.SHERRIFF,L.A.SLOAN,S.TEAGUE,D.A.THOMAS, JRNL AUTH 7 N.WELLAWAY,J.WOJNO-PICON,J.M.WOOLVEN,D.M.COE JRNL TITL INVESTIGATION OF JANUS KINASE (JAK) INHIBITORS FOR LUNG JRNL TITL 2 DELIVERY AND THE IMPORTANCE OF ALDEHYDE OXIDASE METABOLISM. JRNL REF J.MED.CHEM. V. 65 633 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34928601 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01765 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 30877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1567 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2932 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2929 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2790 REMARK 3 BIN R VALUE (WORKING SET) : 0.2915 REMARK 3 BIN FREE R VALUE : 0.3202 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.84 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2415 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.82060 REMARK 3 B22 (A**2) : -5.94710 REMARK 3 B33 (A**2) : 0.12660 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.134 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.123 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.125 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.119 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2514 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3397 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 914 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 71 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 388 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2514 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 305 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3170 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.34 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.11 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 29.1572 19.8271 71.3468 REMARK 3 T TENSOR REMARK 3 T11: -0.0549 T22: -0.0400 REMARK 3 T33: -0.0537 T12: -0.0098 REMARK 3 T13: 0.0055 T23: -0.0163 REMARK 3 L TENSOR REMARK 3 L11: 1.1512 L22: 0.5741 REMARK 3 L33: 0.8420 L12: -0.3012 REMARK 3 L13: -0.0796 L23: -0.0578 REMARK 3 S TENSOR REMARK 3 S11: -0.0745 S12: 0.0188 S13: -0.0601 REMARK 3 S21: 0.0238 S22: 0.0170 S23: 0.0128 REMARK 3 S31: 0.0111 S32: -0.0242 S33: 0.0575 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Q7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292119127. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97242 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30985 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 93.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: APO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.46-1.60 M TRISODIUM CITRATE REMARK 280 (UNTITRATED), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.19550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.19550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.76900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.79650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.76900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.79650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.19550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.76900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.79650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 34.19550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.76900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.79650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A4388 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 817 REMARK 465 HIS A 818 REMARK 465 HIS A 819 REMARK 465 HIS A 820 REMARK 465 HIS A 821 REMARK 465 HIS A 822 REMARK 465 HIS A 823 REMARK 465 ASP A 824 REMARK 465 TYR A 825 REMARK 465 LYS A 826 REMARK 465 ASP A 827 REMARK 465 ASP A 828 REMARK 465 ASP A 829 REMARK 465 ASP A 830 REMARK 465 LYS A 831 REMARK 465 GLU A 832 REMARK 465 ASN A 833 REMARK 465 LEU A 834 REMARK 465 TYR A 835 REMARK 465 PHE A 836 REMARK 465 GLN A 837 REMARK 465 GLY A 838 REMARK 465 ARG A 839 REMARK 465 GLY A 1132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 869 76.73 -118.51 REMARK 500 LYS A 945 -137.54 47.64 REMARK 500 ARG A 975 -14.22 69.76 REMARK 500 ASP A 994 76.87 42.75 REMARK 500 TRP A1106 41.35 -90.97 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Q7I A 839 1132 UNP O60674 JAK2_HUMAN 839 1132 SEQADV 7Q7I MET A 817 UNP O60674 INITIATING METHIONINE SEQADV 7Q7I HIS A 818 UNP O60674 EXPRESSION TAG SEQADV 7Q7I HIS A 819 UNP O60674 EXPRESSION TAG SEQADV 7Q7I HIS A 820 UNP O60674 EXPRESSION TAG SEQADV 7Q7I HIS A 821 UNP O60674 EXPRESSION TAG SEQADV 7Q7I HIS A 822 UNP O60674 EXPRESSION TAG SEQADV 7Q7I HIS A 823 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASP A 824 UNP O60674 EXPRESSION TAG SEQADV 7Q7I TYR A 825 UNP O60674 EXPRESSION TAG SEQADV 7Q7I LYS A 826 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASP A 827 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASP A 828 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASP A 829 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASP A 830 UNP O60674 EXPRESSION TAG SEQADV 7Q7I LYS A 831 UNP O60674 EXPRESSION TAG SEQADV 7Q7I GLU A 832 UNP O60674 EXPRESSION TAG SEQADV 7Q7I ASN A 833 UNP O60674 EXPRESSION TAG SEQADV 7Q7I LEU A 834 UNP O60674 EXPRESSION TAG SEQADV 7Q7I TYR A 835 UNP O60674 EXPRESSION TAG SEQADV 7Q7I PHE A 836 UNP O60674 EXPRESSION TAG SEQADV 7Q7I GLN A 837 UNP O60674 EXPRESSION TAG SEQADV 7Q7I GLY A 838 UNP O60674 EXPRESSION TAG SEQADV 7Q7I SER A 1073 UNP O60674 MET 1073 CONFLICT SEQADV 7Q7I THR A 1076 UNP O60674 PHE 1076 CONFLICT SEQRES 1 A 316 MET HIS HIS HIS HIS HIS HIS ASP TYR LYS ASP ASP ASP SEQRES 2 A 316 ASP LYS GLU ASN LEU TYR PHE GLN GLY ARG ASP PRO THR SEQRES 3 A 316 GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU SEQRES 4 A 316 GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR SEQRES 5 A 316 ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL SEQRES 6 A 316 LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP SEQRES 7 A 316 PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS SEQRES 8 A 316 ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA SEQRES 9 A 316 GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO SEQRES 10 A 316 TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU SEQRES 11 A 316 ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN SEQRES 12 A 316 ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR SEQRES 13 A 316 ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU SEQRES 14 A 316 ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR SEQRES 15 A 316 LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS SEQRES 16 A 316 GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SEQRES 17 A 316 SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL SEQRES 18 A 316 TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR SEQRES 19 A 316 ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG SEQRES 20 A 316 MET ILE GLY ASN ASP LYS GLN GLY GLN SER ILE VAL THR SEQRES 21 A 316 HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO SEQRES 22 A 316 ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET SEQRES 23 A 316 THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER SEQRES 24 A 316 PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP SEQRES 25 A 316 ASN MET ALA GLY MODRES 7Q7I PTR A 1007 TYR MODIFIED RESIDUE MODRES 7Q7I PTR A 1008 TYR MODIFIED RESIDUE HET PTR A1007 16 HET PTR A1008 16 HET 9I8 A4000 26 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 9I8 4-[8-METHOXY-2-[(1-METHYLPYRAZOL-4-YL)AMINO]QUINAZOLIN- HETNAM 2 9I8 6-YL]PHENOL HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 9I8 C19 H17 N5 O2 FORMUL 3 HOH *298(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 SER A 904 1 17 HELIX 3 AA3 SER A 936 LYS A 945 1 10 HELIX 4 AA4 GLU A 946 ILE A 948 5 3 HELIX 5 AA5 ASP A 949 LYS A 970 1 22 HELIX 6 AA6 ALA A 978 ARG A 980 5 3 HELIX 7 AA7 ASP A 994 THR A 998 5 5 HELIX 8 AA8 PRO A 1017 TYR A 1021 5 5 HELIX 9 AA9 ALA A 1022 SER A 1029 1 8 HELIX 10 AB1 SER A 1032 THR A 1049 1 18 HELIX 11 AB2 GLU A 1052 LYS A 1055 5 4 HELIX 12 AB3 SER A 1056 GLY A 1066 1 11 HELIX 13 AB4 GLY A 1071 ASN A 1084 1 14 HELIX 14 AB5 PRO A 1095 TRP A 1106 1 12 HELIX 15 AB6 ASN A 1109 ARG A 1113 5 5 HELIX 16 AB7 SER A 1115 ALA A 1131 1 17 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA1 5 LEU A 925 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 TYR A 918 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.35 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 CRYST1 93.538 101.593 68.391 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010691 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009843 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014622 0.00000